NM_000533.5:c.409C>T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3_ModeratePP5
The NM_000533.5(PLP1):c.409C>T(p.Arg137Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000364 in 1,097,417 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R137G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000533.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 22 
GnomAD4 exome  AF:  0.00000364  AC: 4AN: 1097417Hom.:  0  Cov.: 30 AF XY:  0.00000276  AC XY: 1AN XY: 362785 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
Age Distribution
GnomAD4 genome  Cov.: 22 
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 2    Pathogenic:1Uncertain:1 
- -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 137 of the PLP1 protein (p.Arg137Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with complicated spastic paraplegia and/or Pelizaeus-Merzbacher disease (PMID: 17438221, 24139698). ClinVar contains an entry for this variant (Variation ID: 11098). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects PLP1 function (PMID: 30314286). This variant disrupts the p.Arg137 amino acid residue in PLP1. Other variant(s) that disrupt this residue have been observed in individuals with PLP1-related conditions (PMID: 24139698), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Pelizaeus-Merzbacher disease    Pathogenic:1 
This missense variant (c.409G>T, p.Arg137Trp) has not been observed in population databases (gnomAD). It has been described in the literature (PMID 17438221, PMID 24139698). This nucleotide resides in a region involved in splice site regulation (PMID 16288477), and variant prediction programs suggest a deleterious effect on the PLP1 protein, although no functional studies have been published. It has been found in 2 affected males in a family, related through maternal lines. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at